Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Total Liabilities: 2011-2019

Historic Total Liabilities for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Mar 2019 value amounting to $62.0 million.

  • EyePoint Pharmaceuticals' Total Liabilities rose 47.70% to $62.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $62.0 million, marking a year-over-year increase of 47.70%. This contributed to the annual value of $60.0 million for FY2018, which is 1023.07% up from last year.
  • As of Q1 2019, EyePoint Pharmaceuticals' Total Liabilities stood at $62.0 million, which was up 52.90% from $40.5 million recorded in Q4 2018.
  • EyePoint Pharmaceuticals' Total Liabilities' 5-year high stood at $62.0 million during Q1 2019, with a 5-year trough of $4.3 million in Q4 2017.
  • Its 3-year average for Total Liabilities is $29.4 million, with a median of $40.5 million in 2018.
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Total Liabilities plummeted by 58.74% in 2017, and later skyrocketed by 1,023.07% in 2018.
  • EyePoint Pharmaceuticals' Total Liabilities (Quarterly) stood at $9.5 million in 2015, then plummeted by 47.68% to $5.0 million in 2016, then fell by 13.88% to $4.3 million in 2017, then surged by 844.43% to $40.5 million in 2018, then soared by 47.70% to $62.0 million in 2019.
  • Its Total Liabilities stands at $62.0 million for Q1 2019, versus $40.5 million for Q4 2018 and $41.1 million for Q3 2018.